Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.55 -0.21 (-0.57%)
As of: Sep 9, 2026 · 1:49 PM EDT

Teva Pharmaceutical Industries (TEVA) Assets Growth (5y) (2014 - 2026)

Analysis

Teva Pharmaceutical Industries (TEVA) Assets Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.37 Bn 528.25 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 411.43 Mn 370.18 Mn 17.15 Mn
10 RedHill Biopharma 181.39 Mn 181.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.12%
Mar 31, 2026 -3.96%
Dec 31, 2025 -4.25%
Sep 30, 2025 -4.33%
Jun 30, 2025 -6.11%
Mar 31, 2025 -7.04%
Dec 31, 2024 -7.31%
Sep 30, 2024 -6.11%
Jun 30, 2024 -7.00%
Mar 31, 2024 -6.50%
Dec 31, 2023 -6.45%
Sep 30, 2023 -8.34%
Jun 30, 2023 -8.45%
Mar 31, 2023 -8.88%
Dec 31, 2022 -9.02%
Sep 30, 2022 -12.46%
Jun 30, 2022 -11.86%
Mar 31, 2022 -12.41%
Dec 31, 2021 -12.52%
Sep 30, 2021 -13.49%